Skip to main content
Frank Singer, MD, Endocrinology, Honolulu, HI

Frank D. Singer MD

Diabetes, Lipid Metabolism, Thyroid


Physician

Join to View Full Profile
  • 888 S King StHonolulu, HI 96813

  • Phone+1 808-522-4344

  • Fax+1 808-522-3336

Dr. Singer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Icahn School of Medicine at Mount Sinai (Beth Israel)
    Icahn School of Medicine at Mount Sinai (Beth Israel)Fellowship, Endocrinology, Diabetes, and Metabolism, 1986 - 1988
  • Capital Health Regional Medical Center
    Capital Health Regional Medical CenterResidency, Internal Medicine, 1984 - 1985
  • One Brooklyn Health System/Interfaith Medical Center
    One Brooklyn Health System/Interfaith Medical CenterInternship, Internal Medicine, 1982 - 1983
  • University of the East College of Medicine
    University of the East College of MedicineClass of 1982

Certifications & Licensure

  • HI State Medical License
    HI State Medical License 1992 - 2026
  • OR State Medical License
    OR State Medical License 1985 - 2025
  • NJ State Medical License
    NJ State Medical License 1984 - 2007
  • NY State Medical License
    NY State Medical License 1985 - 1992
  • PA State Medical License
    PA State Medical License 1986 - 1988
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Press Mentions

  • Emmaus Life Sciences Announces Protocol for Study of Pharmaceutical-Grade L-glutamine for the Treatment of Diabetes
    Emmaus Life Sciences Announces Protocol for Study of Pharmaceutical-Grade L-glutamine for the Treatment of DiabetesJune 24th, 2019

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: